<?xml version="1.0"?>
<rss version="2.0">
<channel>
<title>Inbox Robot: Drug Labels News</title>
<link>http://www.inboxrobot.com/news/drug-labels</link><description>Constantly updated news and information about a variety of topics.</description><item>
<title>Teva Tells It Like It Is</title>
<link>http://www.inboxrobot.com/news.php?fid=185272729</link>
<pubDate>27 Aug 2008 16:55 GMT</pubDate>
<description>
found out: the devil is often in the details. It&apos;s not good enough to just see -- only seen once the full results are presented  ...
</description>
</item><item>
<title>The Dallas Morning News Cheryl Hall column: Attorney predicts next big corporate scandal will be off-label drug marketing</title>
<link>http://www.inboxrobot.com/news.php?fid=185249781</link>
<pubDate>27 Aug 2008 14:34 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Adagio study shows Azilect slows progression of Parkinson&apos;s</title>
<link>http://www.inboxrobot.com/news.php?fid=185226804</link>
<pubDate>27 Aug 2008 11:56 GMT</pubDate>
<description>
Adagio study shows Azilect slows progression of Parkinsons A bid by Israel&apos;s Teva and Denmark&apos;s Lundbeck to get expanded use of Azilect has  ...
</description>
</item><item>
<title>Drug Safety Updates For Elan, Biogen, Amylin, and Lilly</title>
<link>http://www.inboxrobot.com/news.php?fid=185212050</link>
<pubDate>27 Aug 2008 10:18 GMT</pubDate>
<description>
...  the agency also said that it is working with the companies to update the drug label about PML occurring in patients taking Tysabri alone, and not just in combination with  ...
</description>
</item><item>
<title>Attorney predicts next big corporate scandal will be off-label drug marketing</title>
<link>http://www.inboxrobot.com/news.php?fid=185202845</link>
<pubDate>27 Aug 2008 09:06 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Biogen, Elan Rise After Agreement on Revising Tysabri Drug Label</title>
<link>http://www.inboxrobot.com/news.php?fid=185084398</link>
<pubDate>26 Aug 2008 17:23 GMT</pubDate>
<description>
 ...
</description>
</item><item>
<title>Drug Safety Updates For Elan, Biogen, Amylin &amp; Lilly</title>
<link>http://www.inboxrobot.com/news.php?fid=185062517</link>
<pubDate>26 Aug 2008 15:29 GMT</pubDate>
<description>
...  the agency also said that it is working with the companies to update the drug label about PML occuring in patients taking Tysabri alone, and not just in combination with  ...
</description>
</item><item>
<title>LegalView Highlights Top Brain Injury Rehabilitation Hospitals in the United States - 5.3 Million Americans Suffer from TBI</title>
<link>http://www.inboxrobot.com/news.php?fid=185008721</link>
<pubDate>26 Aug 2008 09:07 GMT</pubDate>
<description>
LegalView provided information on the top traumatic brain injury rehabilitation clinics and hospitals in the United States as the International Brain Injury Association reports that  ...
</description>
</item><item>
<title>FDA orders changes to Tysabri label</title>
<link>http://www.inboxrobot.com/news.php?fid=185008652</link>
<pubDate>26 Aug 2008 09:07 GMT</pubDate>
<description>
## Prescribing instructions for Elan and Biogen&apos;s drug Tysabri should note cases of a serious brain infection in patients using it as their sole treatment  ...
</description>
</item><item>
<title>UPDATE 1-US FDA wants Biogen, Elan drug warning revised</title>
<link>http://www.inboxrobot.com/news.php?fid=184926625</link>
<pubDate>25 Aug 2008 20:25 GMT</pubDate>
<description>
WASHINGTON, Aug 25 (Reuters) - Prescribing instructions for Biogen Idec (BIIB.O: ) drug Tysabri should note cases of a serious brain infection in patients using it  ...
</description>
</item><item>
<title>Amylin shares gain ground on outlook for Byetta</title>
<link>http://www.inboxrobot.com/news.php?fid=184902053</link>
<pubDate>25 Aug 2008 17:31 GMT</pubDate>
<description>
The stock gained $1.19, or 4.5 percent, to reach $27.77 in morning trading as analysts continued to brush off the impact of  ...
</description>
</item><item>
<title>Moffitt Cancer Center Chief Participates in Clinical Trial Resulting in FDA Approval of New Label for Myelodysplastic Therapy VIDAZA</title>
<link>http://www.inboxrobot.com/news.php?fid=184877098</link>
<pubDate>25 Aug 2008 14:47 GMT</pubDate>
<description>
Moffitt Cancer Center Chief Participates in Clinical Trial Resulting in FDA Approval of New Label for Myelodysplastic Therapy VIDAZA Study Results find that VIDAZA is  ...
</description>
</item><item>
<title>Drug Companies The New Sin Stocks</title>
<link>http://www.inboxrobot.com/news.php?fid=184847147</link>
<pubDate>25 Aug 2008 10:32 GMT</pubDate>
<description>
Drug Companies  The New Sin Stocks It is part of the American dream to put a dollar into a company stock today, and get lots  ...
</description>
</item><item>
<title>Drug Companies - The New Sin Stocks</title>
<link>http://www.inboxrobot.com/news.php?fid=184803268</link>
<pubDate>25 Aug 2008 01:51 GMT</pubDate>
<description>
Drug Companies - The New Sin Stocks By John Carey Aug 23, 2008 - 10:19:36 PM It is part of the American dream to put  ...
</description>
</item></channel>
</rss>
